臨床試験イメージングの世界市場レポート 2025年

臨床試験イメージング市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は9.3％で、22億6,000万米ドルに成長します。予測期間における成長の背景には、慢性疾患の増加、研究開発費の増加、高齢者人口の増加、臨床研究の増加、受託研究機関の増加などがあります。予測期間における主な動向としては、イメージングモダリティを強化する技術的進歩、能力および製品提供の拡大に向けた市場プレイヤーの戦略的イニシアティブ、医薬品開発におけるイメージングベースのアプローチの採用、分子イメージングおよびAI駆動型解析の進歩、製品イノベーションなどが挙げられます。

慢性疾患の有病率の増加は、今後数年間の臨床試験イメージング市場の拡大を促進すると予想されます。慢性疾患は、継続的な医学的治療を必要とし、日常活動や生活の質に大きな影響を与える長期的な疾患です。このような慢性疾患の増加は、大気汚染、化学物質、毒素への曝露、ライフスタイルの変化、遺伝的影響などの要因に起因しています。臨床試験イメージングは、患者を効率的にモニタリングし、患者の状態や治療効果に関する貴重な洞察を提供し、患者のアドヒアランスと満足度の向上に役立つという重要な役割を果たしています。例えば、米国の国立医学図書館である国立生物工学情報センター（NCBI）は、2023年1月に、2050年までに、少なくとも1つの慢性疾患を持つ50歳以上の個人の数が、2020年の7,152万人から1億4,266万人へと99.5％増加すると予測しました。その結果、慢性疾患の有病率の増加が臨床試験イメージング市場の成長を牽引しています。

臨床試験イメージング市場の主要企業は、改善されたソリューションを提供し、臨床試験の効率を高めるために、クラウドベースのイメージングツールの開発に注力しています。これらのツールはクラウドコンピューティング技術を活用し、医療画像の保存、管理、分析を行う。例えば、2023年3月、米国の高度配電システムメーカーであるクラリオンは、革新的なクラウドベースの画像ビューアツールを発表しました。このツールは、高解像度の画像をリアルタイムでオンデマンドに閲覧・操作することができ、手作業を必要としない読み取り品質のアクセスを提供します。このツールは、画像閲覧プロセスを合理化し、簡単で安全、かつコンプライアンスに準拠したデータアクセシビリティを確保することで、ユーザーが治験被験者に関する貴重な洞察を得られるようにします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界臨床試験イメージング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の臨床試験イメージング市場：成長率分析
• 世界の臨床試験イメージング市場の実績：規模と成長, 2019-2024
• 世界の臨床試験イメージング市場の予測：規模と成長, 2024-2029, 2034F
• 世界臨床試験イメージング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の臨床試験イメージング市場製品とサービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• サービス
• ソフトウェア
• 世界の臨床試験イメージング市場：モダリティ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンピュータ断層撮影
• 磁気共鳴画像法
• 心エコー検査
• 核医学
• 陽電子放出断層撮影
• X線
• 超音波
• 光干渉断層撮影
• その他のモダリティ
• 世界の臨床試験イメージング市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 神経学
• 心臓病学
• 内分泌学
• 皮膚科
• 血液学
• その他の用途
• 世界の臨床試験イメージング市場販売元別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 直接販売
• 入札販売
• 世界の臨床試験イメージング市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 契約調査機関
• 製薬およびバイオテクノロジー企業
• 医療機器メーカー
• 学術機関および政府調査機関
• その他のエンドユーザー
• 世界の臨床試験イメージング市場、サービスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断のための画像診断サービス
• 画像取得サービス
• 画像解析サービス
• 画像管理およびアーカイブサービス
• 世界の臨床試験イメージング市場ソフトウェアの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 分析用画像ソフトウェア
• 画像処理ソフトウェア
• 放射線情報システム（RIS）
• 画像アーカイブおよび通信システム（PACS）

第7章 地域別・国別分析

• 世界の臨床試験イメージング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の臨床試験イメージング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 臨床試験イメージング市場：競合情勢
• 臨床試験イメージング市場：企業プロファイル
  • Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • Labcorp Drug Development Overview, Products and Services, Strategy and Financial Analysis
  • Icon Plc Overview, Products and Services, Strategy and Financial Analysis
  • PPD Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Syneos Health Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Charles River Laboratories
• Parexel International Corporation
• Clario
• Medpace Inc.
• Medidata Solution Inc.
• Biotelemetry Inc.
• WIRB-Copernicus Group
• ProScan Imaging LLC
• Invicro LLC
• Perspectum
• Radiant Sage LLC
• Worldcare Clinical LLC
• Intrinsic Imaging LLC
• Datatrak Inc.
• IXICO Plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 臨床試験イメージング市場2029：新たな機会を提供する国
• 臨床試験イメージング市場2029：新たな機会を提供するセグメント
• 臨床試験イメージング市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Clinical trial imaging involves utilizing medical imaging techniques such as magnetic resonance imaging (MRI), computed tomography (CT) scans, and X-rays to capture detailed internal images of participants during clinical trials. These images play a vital role in monitoring disease progression, evaluating treatment efficacy, and ensuring patient safety, making it an essential component in assessing the biological impact of new therapies and interventions.

The primary products and services in clinical trial imaging include services and software. Clinical trial imaging services entail providing specialized imaging techniques and methodologies to support the research and development phases of clinical trials. Various modalities encompass computed tomography, magnetic resonance imaging, echocardiography, nuclear medicine, positron emission tomography, X-ray, ultrasound, optical coherence tomography, among others. These services cater to various applications such as oncology, neurology, cardiology, endocrinology, dermatology, hematology, and others, distributed through direct sales and tender sales. End-users include contract research organizations, pharmaceutical and biotechnology companies, medical device manufacturers, academic and government research institutes, among others.

The clinical trial imaging market research report is one of a series of new reports from The Business Research Company that provides clinical trial imaging market statistics, including clinical trial imaging industry global market size, regional shares, competitors with a clinical trial imaging market share, detailed clinical trial imaging market segments, market trends, and opportunities, and any further data you may need to thrive in the clinical trial imaging industry. This clinical trial imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical trial imaging market size has grown strongly in recent years. It will grow from $1.44 billion in 2024 to $1.58 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increased sales and the distribution of clinical imaging software and services, increased risks of breast cancer, increased healthcare spending, rise in healthcare expenditure results in improved infrastructure, increased research and development spending by the pharmaceutical and biotechnological companies.

The clinical trial imaging market size is expected to see strong growth in the next few years. It will grow to $2.26 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to growing chronic diseases, rising research and development expenditures, an increasing geriatric population, a growing number of clinical studies, and an increasing number of contract research organizations. Major trends in the forecast period include technological advancements enhancing imaging modalities, strategic initiatives by market players to expand capabilities and offerings, adoption of imaging-based approaches in drug development, advancements in molecular imaging and AI-driven analysis, and product innovation.

The growing prevalence of chronic diseases is expected to drive the expansion of the clinical trial imaging market in the coming years. Chronic diseases are long-term conditions that require continuous medical attention and can significantly affect daily activities and quality of life. This increase in chronic diseases is attributed to factors such as exposure to air pollution, chemicals, and toxins, lifestyle changes, and genetic influences. Clinical trial imaging plays a crucial role in monitoring patients efficiently, providing valuable insights into their condition and the effects of treatments, which helps improve patient adherence and satisfaction. For example, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected in January 2023 that by 2050, the number of individuals aged 50 and above with at least one chronic illness will rise by 99.5%, from 71.52 million in 2020 to 142.66 million. As a result, the increasing prevalence of chronic diseases is driving the growth of the clinical trial imaging market.

Major players in the clinical trial imaging market are focusing on developing cloud-based imaging tools to offer improved solutions and enhance clinical trial efficiency. These tools leverage cloud computing technology to store, manage, and analyze medical images. For instance, in March 2023, Clarion, a US-based manufacturer of advanced power distribution systems, introduced an innovative cloud-based image viewer tool. This tool enables real-time, on-demand viewing and manipulation of high-resolution images, providing read-quality access without the need for manual steps. It streamlines the image viewing process, ensuring easy, secure, and compliant data accessibility, empowering users to gain valuable insights into trial subjects.

In March 2023, Medica, a UAE-based medical company, acquired RadMD for an undisclosed sum. This strategic acquisition enables Medica to enter the clinical trials market, utilizing RadMD's expertise to enhance cost-efficiency and streamline drug and device development processes for pharmaceutical, biotech, and contract research organizations (CROs). RadMD, based in the US, specializes in offering clinical trial imaging solutions.

Major companies operating in the clinical trial imaging market are Koninklijke Philips N.V., Labcorp Drug Development, Icon Plc, PPD Inc., Syneos Health, Charles River Laboratories, Parexel International Corporation, Clario, Medpace Inc., Medidata Solution Inc., Biotelemetry Inc., WIRB-Copernicus Group, ProScan Imaging LLC, Invicro LLC, Perspectum, Radiant Sage LLC, Worldcare Clinical LLC, Intrinsic Imaging LLC, Datatrak Inc., IXICO Plc, Calyx Inc., Resonance Health Ltd., Anagram-ESIC SL

North America was the largest region in the clinical trial imaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical trial imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical trial imaging market consists of revenues earned by entities by providing services such as image protocol development, data management and integration, image processing, and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial imaging market also includes sales of analysis tools, clinical trial management systems, and compliance tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Trial Imaging Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical trial imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical trial imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical trial imaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product And Services: Services; Software
• 2) By Modality: Computed Tomography; Magnetic Resonance Imaging; Echocardiography; Nuclear Medicine; Positron Emission Tomography; X-Ray; Ultrasound; Optical Coherence Tomography; Other Modalities
• 3) By Application: Oncology; Neurology; Cardiology; Endocrinology; Dermatology; Hematology; Other Applications
• 4) By Distributer: Direct Sales; Tender Sales
• 5) By End User: Contract Research Organizations; Pharmaceutical And Biotechnology Companies; Medical Device Manufacturers; Academic And Government Research Institutes; Other End-Users
• Subsegments:
• 1) By Services: Imaging Services For Diagnostics; Image Acquisition Services; Image Analysis Services; Image Management And Archiving Services
• 2) By Software: Imaging Software For Analysis; Image Processing Software; Radiology Information Systems (RIS); Picture Archiving And Communication Systems (PACS)
• Companies Mentioned: Koninklijke Philips N.V.; Labcorp Drug Development; Icon Plc; PPD Inc.; Syneos Health
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Trial Imaging Market Characteristics

3. Clinical Trial Imaging Market Trends And Strategies

4. Clinical Trial Imaging Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Clinical Trial Imaging Growth Analysis And Strategic Analysis Framework

• 5.1. Global Clinical Trial Imaging PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Clinical Trial Imaging Market Growth Rate Analysis
• 5.4. Global Clinical Trial Imaging Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Clinical Trial Imaging Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Clinical Trial Imaging Total Addressable Market (TAM)

6. Clinical Trial Imaging Market Segmentation

• 6.1. Global Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Services
• Software
• 6.2. Global Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Computed Tomography
• Magnetic Resonance Imaging
• Echocardiography
• Nuclear Medicine
• Positron Emission Tomography
• X-Ray
• Ultrasound
• Optical Coherence Tomography
• Other Modalities
• 6.3. Global Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Neurology
• Cardiology
• Endocrinology
• Dermatology
• Hematology
• Other Applications
• 6.4. Global Clinical Trial Imaging Market, Segmentation By Distributer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Sales
• Tender Sales
• 6.5. Global Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contract Research Organizations
• Pharmaceutical And Biotechnology Companies
• Medical Device Manufacturers
• Academic And Government Research Institutes
• Other End-Users
• 6.6. Global Clinical Trial Imaging Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Services For Diagnostics
• Image Acquisition Services
• Image Analysis Services
• Image Management And Archiving Services
• 6.7. Global Clinical Trial Imaging Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Software For Analysis
• Image Processing Software
• Radiology Information Systems (RIS)
• Picture Archiving And Communication Systems (PACS)

7. Clinical Trial Imaging Market Regional And Country Analysis

• 7.1. Global Clinical Trial Imaging Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Clinical Trial Imaging Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Clinical Trial Imaging Market

• 8.1. Asia-Pacific Clinical Trial Imaging Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Clinical Trial Imaging Market

• 9.1. China Clinical Trial Imaging Market Overview
• 9.2. China Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Clinical Trial Imaging Market

• 10.1. India Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Clinical Trial Imaging Market

• 11.1. Japan Clinical Trial Imaging Market Overview
• 11.2. Japan Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Clinical Trial Imaging Market

• 12.1. Australia Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Clinical Trial Imaging Market

• 13.1. Indonesia Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Clinical Trial Imaging Market

• 14.1. South Korea Clinical Trial Imaging Market Overview
• 14.2. South Korea Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Clinical Trial Imaging Market

• 15.1. Western Europe Clinical Trial Imaging Market Overview
• 15.2. Western Europe Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Clinical Trial Imaging Market

• 16.1. UK Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Clinical Trial Imaging Market

• 17.1. Germany Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Clinical Trial Imaging Market

• 18.1. France Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Clinical Trial Imaging Market

• 19.1. Italy Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Clinical Trial Imaging Market

• 20.1. Spain Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Clinical Trial Imaging Market

• 21.1. Eastern Europe Clinical Trial Imaging Market Overview
• 21.2. Eastern Europe Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Clinical Trial Imaging Market

• 22.1. Russia Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Clinical Trial Imaging Market

• 23.1. North America Clinical Trial Imaging Market Overview
• 23.2. North America Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Clinical Trial Imaging Market

• 24.1. USA Clinical Trial Imaging Market Overview
• 24.2. USA Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Clinical Trial Imaging Market

• 25.1. Canada Clinical Trial Imaging Market Overview
• 25.2. Canada Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Clinical Trial Imaging Market

• 26.1. South America Clinical Trial Imaging Market Overview
• 26.2. South America Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Clinical Trial Imaging Market

• 27.1. Brazil Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Clinical Trial Imaging Market

• 28.1. Middle East Clinical Trial Imaging Market Overview
• 28.2. Middle East Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Clinical Trial Imaging Market

• 29.1. Africa Clinical Trial Imaging Market Overview
• 29.2. Africa Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Clinical Trial Imaging Market Competitive Landscape And Company Profiles

• 30.1. Clinical Trial Imaging Market Competitive Landscape
• 30.2. Clinical Trial Imaging Market Company Profiles
  • 30.2.1. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Labcorp Drug Development Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Icon Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. PPD Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Syneos Health Overview, Products and Services, Strategy and Financial Analysis

31. Clinical Trial Imaging Market Other Major And Innovative Companies

• 31.1. Charles River Laboratories
• 31.2. Parexel International Corporation
• 31.3. Clario
• 31.4. Medpace Inc.
• 31.5. Medidata Solution Inc.
• 31.6. Biotelemetry Inc.
• 31.7. WIRB-Copernicus Group
• 31.8. ProScan Imaging LLC
• 31.9. Invicro LLC
• 31.10. Perspectum
• 31.11. Radiant Sage LLC
• 31.12. Worldcare Clinical LLC
• 31.13. Intrinsic Imaging LLC
• 31.14. Datatrak Inc.
• 31.15. IXICO Plc

32. Global Clinical Trial Imaging Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Trial Imaging Market

34. Recent Developments In The Clinical Trial Imaging Market

35. Clinical Trial Imaging Market High Potential Countries, Segments and Strategies

• 35.1 Clinical Trial Imaging Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Clinical Trial Imaging Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Clinical Trial Imaging Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer